Dr. David A. Eichenbaum, M.D.
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- University of South Florida College of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 902
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: University of South Florida College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
FL license ME90466 -
Retina Specialist (Ophthalmology) Physician
FL license ME90466
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- HCA Florida Northside Hospital Saint Petersburg, FL
Medical groups
- Pautler Cohen Findlay Eichenbaum White and Crane MDs PA (8 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 902
- Services billed
- 94,790
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 37,080 | 130 |
| Imaging of retina | 1,940 | 809 |
| Injection, aflibercept, 1 mg | 1,660 | 178 |
| Injection of drug into eye | 1,650 | 396 |
| Injection, ranibizumab, 0.1 mg | 1,553 | 68 |
| Established patient complete exam of visual system | 949 | 658 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 810 | 24 |
| Photography of the retina | 476 | 420 |
| Established patient problem focused exam of visual system | 382 | 267 |
| Extended exam of the back part of the eye with optic nerve drawing | 373 | 287 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in St Petersburg, FL | 124 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in St Petersburg, FL | 45 |
| Brimonidine Tartrate Other prescribers in St Petersburg, FL | 32 |
| Gentamicin Sulfate Other prescribers in St Petersburg, FL | 27 |
| Ketorolac Tromethamine Other prescribers in St Petersburg, FL | 24 |
| Timolol Maleate Other prescribers in St Petersburg, FL | 21 |
| Prolensa (bromfenac sodium) | 21 |
| Latanoprost Other prescribers in St Petersburg, FL | 14 |
| Lotemax Sm (loteprednol etabonate) | 14 |
| Atropine Sulfate | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 245 payments worth $244,967 in total to this clinician.
| Regeneron Healthcare Solutions, Inc. | $111,178 |
|---|---|
| Apellis Pharmaceuticals, Inc. | $44,781 |
| Ocular Therapeutix, Inc. | $31,609 |
| AbbVie Inc. | $20,949 |
| Astellas Pharma US Inc | $14,762 |
| Genentech USA, Inc. | $10,856 |
| Genentech, Inc. | $3,413 |
| Ani Pharmaceuticals, Inc. | $2,465 |
| Consulting Fee | $138,402 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $68,868 |
| Speaking at a medical education program | $21,724 |
| Travel and Lodging | $8,772 |
| Food and Beverage | $5,150 |
| Honoraria | $2,050 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Jan 10, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $13,260 |
| Regeneron Healthcare Solutions, Inc. May 6, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $11,050 |
| Regeneron Healthcare Solutions, Inc. Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $11,050 |
| Regeneron Healthcare Solutions, Inc. Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $11,050 |
| Regeneron Healthcare Solutions, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $11,050 |
| AbbVie Inc. May 5, 2025 | Consulting Fee | $10,763 |
| Apellis Pharmaceuticals, Inc. Sep 10, 2025 | Speaking at a medical education program Syfovre · Ophthalmology | $7,095 |
| Regeneron Healthcare Solutions, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $6,630 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $6,630 |
| Genentech USA, Inc. Aug 14, 2025 | Consulting Fee Vabysmo · Immunology and Ophthalmology | $6,300 |
All 137 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Dec 19, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to LITTLE FALLS, NJ · in-kind | $28.70 |
| Regeneron Healthcare Solutions, Inc. Dec 19, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to LITTLE FALLS, NJ · in-kind | $28.00 |
| Regeneron Healthcare Solutions, Inc. Dec 19, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to LITTLE FALLS, NJ · in-kind | $16.00 |
| Regeneron Healthcare Solutions, Inc. Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $11,050 |
| Ocular Therapeutix, Inc. Dec 8, 2025 | Consulting Fee | $750 |
| Apellis Pharmaceuticals, Inc. Nov 28, 2025 | Consulting Fee Syfovre · Ophthalmology | $946 |
| Ocular Therapeutix, Inc. Nov 23, 2025 | Consulting Fee | $1,000 |
| Regeneron Healthcare Solutions, Inc. Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $2,597 |
| Astellas Pharma US Inc Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Izervay · Ophthalmology | $6,000 |
| Ani Pharmaceuticals, Inc. Nov 19, 2025 | Honoraria PURIFIED CORTROPHIN GEL · Treatment of certain chronic autoimmune disorders including acute exacerbations | $2,050 |
| Astellas Pharma US Inc Nov 19, 2025 | Travel and Lodging Izervay · Ophthalmology · travel to Tampa, FL | $40.10 |
| Regeneron Healthcare Solutions, Inc. Nov 15, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to LITTLE FALLS, NJ · in-kind | $785 |
| Regeneron Healthcare Solutions, Inc. Nov 15, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to LITTLE FALLS, NJ · in-kind | $218 |
| AbbVie Inc. Nov 12, 2025 | Consulting Fee OZURDEX · EYE CARE | $513 |
| AbbVie Inc. Nov 3, 2025 | Consulting Fee | $1,025 |
| Apellis Pharmaceuticals, Inc. Oct 24, 2025 | Consulting Fee Syfovre · Ophthalmology | $1,656 |
| Ocular Therapeutix, Inc. Oct 15, 2025 | Consulting Fee | $1,000 |
| Astellas Pharma US Inc Oct 2, 2025 | Consulting Fee Izervay · Ophthalmology | $3,250 |
| Apellis Pharmaceuticals, Inc. Oct 1, 2025 | Speaking at a medical education program Syfovre · Ophthalmology | $1,500 |
| Ocular Therapeutix, Inc. Sep 30, 2025 | Consulting Fee | $1,000 |
| Ocular Therapeutix, Inc. Sep 30, 2025 | Consulting Fee | $750 |
| Regeneron Healthcare Solutions, Inc. Sep 19, 2025 | Consulting Fee EYLEA; EYLEA HD · OPHTHALMOLOGY | $3,315 |
| Regeneron Healthcare Solutions, Inc. Sep 19, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,105 |
| Apellis Pharmaceuticals, Inc. Sep 10, 2025 | Speaking at a medical education program Syfovre · Ophthalmology | $7,095 |
| Regeneron Healthcare Solutions, Inc. Sep 5, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to LITTLE FALLS, NJ · in-kind | $217 |
| Genentech USA, Inc. Sep 4, 2025 | Consulting Fee Vabysmo · Immunology and Ophthalmology | $900 |
| Apellis Pharmaceuticals, Inc. Aug 29, 2025 | Consulting Fee Syfovre · Ophthalmology | $1,892 |
| Apellis Pharmaceuticals, Inc. Aug 29, 2025 | Consulting Fee Syfovre · Ophthalmology | $1,419 |
| Apellis Pharmaceuticals, Inc. Aug 26, 2025 | Travel and Lodging Syfovre · Ophthalmology · travel to Bonita Springs, FL · in-kind | $1,188 |
| Apellis Pharmaceuticals, Inc. Aug 26, 2025 | Travel and Lodging Syfovre · Ophthalmology · travel to Bonita Springs, FL | $102 |
| Genentech USA, Inc. Aug 14, 2025 | Consulting Fee Vabysmo · Immunology and Ophthalmology | $6,300 |
| Ocular Therapeutix, Inc. Aug 11, 2025 | Consulting Fee | $1,000 |
| Ocular Therapeutix, Inc. Jul 31, 2025 | Consulting Fee | $1,000 |
| Ocular Therapeutix, Inc. Jul 31, 2025 | Consulting Fee | $500 |
| Apellis Pharmaceuticals, Inc. Jul 30, 2025 | Speaking at a medical education program Syfovre · Ophthalmology | $6,149 |
| Ocular Therapeutix, Inc. Jul 30, 2025 | Consulting Fee | $500 |
| Regeneron Healthcare Solutions, Inc. Jul 25, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $2,210 |
| Regeneron Healthcare Solutions, Inc. Jul 25, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,105 |
| Ocular Therapeutix, Inc. Jul 21, 2025 | Consulting Fee | $500 |
| Apellis Pharmaceuticals, Inc. Jul 18, 2025 | Consulting Fee Syfovre · Ophthalmology | $473 |
| Apellis Pharmaceuticals, Inc. Jul 17, 2025 | Travel and Lodging Syfovre · Ophthalmology · travel to Sarasota, FL · in-kind | $763 |
| Ocular Therapeutix, Inc. Jul 15, 2025 | Consulting Fee | $250 |
| Regeneron Healthcare Solutions, Inc. Jul 15, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to TAMPA, FL · in-kind | $26.32 |
| Regeneron Healthcare Solutions, Inc. Jul 9, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $2,210 |
| Regeneron Pharmaceuticals, Inc. Jul 9, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,105 |
| Regeneron Healthcare Solutions, Inc. Jul 1, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to WESTLAKE, OH · in-kind | $28.00 |
| Regeneron Healthcare Solutions, Inc. Jul 1, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to WESTLAKE, OH · in-kind | $26.32 |
| Regeneron Healthcare Solutions, Inc. Jul 1, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to WESTLAKE, OH · in-kind | $25.00 |
| Regeneron Healthcare Solutions, Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $2,763 |
| Regeneron Healthcare Solutions, Inc. Jun 20, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $1,879 |
| Apellis Pharmaceuticals, Inc. Jun 13, 2025 | Consulting Fee Syfovre · Ophthalmology | $1,892 |
| AbbVie Inc. Jun 13, 2025 | Consulting Fee | $1,025 |
| Astellas Pharma US Inc Jun 7, 2025 | Compensation for services other than consulting (speaking, faculty) Izervay · Ophthalmology | $3,600 |
| Regeneron Healthcare Solutions, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $6,630 |
| Genentech, Inc. Jun 4, 2025 | Consulting Fee Susvimo · Immunology and Ophthalmology | $488 |
| Genentech, Inc. Jun 4, 2025 | Consulting Fee Vabysmo · Immunology and Ophthalmology | $488 |
| Astellas Pharma US Inc May 30, 2025 | Compensation for services other than consulting (speaking, faculty) Izervay · Ophthalmology | $1,200 |
| Regeneron Healthcare Solutions, Inc. May 30, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,105 |
| Ocular Therapeutix, Inc. May 29, 2025 | Consulting Fee | $1,000 |
| Apellis Pharmaceuticals, Inc. May 22, 2025 | Consulting Fee Syfovre · Ophthalmology | $2,838 |
| Ocular Therapeutix, Inc. May 19, 2025 | Consulting Fee | $4,000 |
| Sanofi US Services Inc. May 19, 2025 | Consulting Fee | $441 |
| Ocular Therapeutix, Inc. May 18, 2025 | Consulting Fee | $2,000 |
| W. L. Gore & Associates, Inc. May 9, 2025 | Consulting Fee Product in Development · Devices | $900 |
| Regeneron Healthcare Solutions, Inc. May 6, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $11,050 |
| Regeneron Healthcare Solutions, Inc. May 6, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to WESTLAKE, OH · in-kind | $469 |
| AbbVie Inc. May 5, 2025 | Consulting Fee | $10,763 |
| AbbVie Inc. May 5, 2025 | Consulting Fee | $4,100 |
| AbbVie Inc. May 5, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind | $206 |
| AbbVie Inc. May 5, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind | $56.00 |
| AbbVie Inc. May 5, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind | $37.00 |
| Regeneron Healthcare Solutions, Inc. May 3, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to WESTLAKE, OH · in-kind | $281 |
| Genentech, Inc. Apr 29, 2025 | Consulting Fee Susvimo · Immunology and Ophthalmology | $244 |
| Genentech, Inc. Apr 29, 2025 | Consulting Fee Vabysmo · Immunology and Ophthalmology | $244 |
| Ocular Therapeutix, Inc. Apr 25, 2025 | Consulting Fee | $5,000 |
| Apellis Pharmaceuticals, Inc. Apr 18, 2025 | Consulting Fee Syfovre · Ophthalmology | $4,730 |
| Ocular Therapeutix, Inc. Apr 18, 2025 | Consulting Fee | $1,000 |
| AbbVie Inc. Apr 18, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind | $521 |
| AbbVie Inc. Apr 18, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind | $206 |
| Regeneron Healthcare Solutions, Inc. Apr 18, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to WESTLAKE, OH · in-kind | $174 |
| Regeneron Healthcare Solutions, Inc. Apr 18, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to WESTLAKE, OH · in-kind | $124 |
| AbbVie Inc. Apr 18, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind | $77.75 |
| Ocular Therapeutix, Inc. Apr 14, 2025 | Consulting Fee | $1,000 |
| Ocular Therapeutix, Inc. Apr 13, 2025 | Consulting Fee | $500 |
| Genentech USA, Inc. Apr 11, 2025 | Consulting Fee Susvimo · Immunology and Ophthalmology | $2,925 |
| Regeneron Healthcare Solutions, Inc. Apr 4, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,658 |
| Regeneron Healthcare Solutions, Inc. Apr 4, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,105 |
| Regeneron Healthcare Solutions, Inc. Apr 4, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,105 |
| Ocular Therapeutix, Inc. Apr 4, 2025 | Consulting Fee | $500 |
| Apellis Pharmaceuticals, Inc. Mar 28, 2025 | Consulting Fee Syfovre · Ophthalmology | $2,365 |
| Ocular Therapeutix, Inc. Mar 26, 2025 | Consulting Fee | $500 |
| Apellis Pharmaceuticals, Inc. Mar 25, 2025 | Speaking at a medical education program Syfovre · Ophthalmology | $1,500 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $1,105 |
| AbbVie Inc. Mar 18, 2025 | Consulting Fee OZURDEX · EYE CARE | $769 |
| Regeneron Healthcare Solutions, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $11,050 |
| Ocular Therapeutix, Inc. Mar 10, 2025 | Consulting Fee | $1,500 |
| Apellis Pharmaceuticals, Inc. Mar 9, 2025 | Speaking at a medical education program Syfovre · Ophthalmology | $4,730 |
| Apellis Pharmaceuticals, Inc. Mar 9, 2025 | Travel and Lodging Syfovre · Ophthalmology · travel to Sarasota, FL · in-kind | $465 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $6,630 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $5,525 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $2,210 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to CHICAGO, IL · in-kind | $58.50 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to CHICAGO, IL · in-kind | $56.00 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to CHICAGO, IL · in-kind | $24.00 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to CHICAGO, IL · in-kind | $18.00 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to CHICAGO, IL · in-kind | $12.66 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to CHICAGO, IL · in-kind | $12.66 |
| Ocular Therapeutix, Inc. Mar 6, 2025 | Consulting Fee | $1,000 |
| Ocular Therapeutix, Inc. Mar 6, 2025 | Consulting Fee | $1,000 |
| Ocular Therapeutix, Inc. Mar 3, 2025 | Consulting Fee | $1,000 |
| Regeneron Healthcare Solutions, Inc. Feb 27, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to AUSTIN, TX · in-kind | $249 |
| Regeneron Healthcare Solutions, Inc. Feb 27, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to AUSTIN, TX · in-kind | $40.71 |
| Regeneron Healthcare Solutions, Inc. Feb 27, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to AUSTIN, TX · in-kind | $28.00 |
| Regeneron Healthcare Solutions, Inc. Feb 27, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to AUSTIN, TX · in-kind | $26.60 |
| Regeneron Healthcare Solutions, Inc. Feb 27, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to AUSTIN, TX · in-kind | $16.00 |
| Regeneron Healthcare Solutions, Inc. Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) EYLEA HD · OPHTHALMOLOGY | $11,050 |
| Regeneron Healthcare Solutions, Inc. Feb 21, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to AUSTIN, TX · in-kind | $1,720 |
| Apellis Pharmaceuticals, Inc. Feb 20, 2025 | Speaking at a medical education program Syfovre · Ophthalmology | $750 |
| Beaver-visitec International, Inc. Feb 7, 2025 | Consulting Fee | $1,635 |
| Genentech, Inc. Feb 6, 2025 | Consulting Fee Vabysmo · Immunology and Ophthalmology | $975 |
| Ocular Therapeutix, Inc. Feb 3, 2025 | Consulting Fee | $1,000 |
| Apellis Pharmaceuticals, Inc. Jan 24, 2025 | Consulting Fee Syfovre · Ophthalmology | $1,414 |
| Apellis Pharmaceuticals, Inc. Jan 24, 2025 | Consulting Fee | $478 |
| AbbVie Inc. Jan 22, 2025 | Consulting Fee | $1,025 |
| Ocular Therapeutix, Inc. Jan 20, 2025 | Consulting Fee | $500 |
| Genentech, Inc. Jan 16, 2025 | Consulting Fee Susvimo · Immunology and Ophthalmology | $488 |
| Genentech, Inc. Jan 16, 2025 | Consulting Fee Vabysmo · Immunology and Ophthalmology | $488 |
| Ocular Therapeutix, Inc. Jan 14, 2025 | Consulting Fee | $500 |
| Regeneron Healthcare Solutions, Inc. Jan 10, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $13,260 |
| Regeneron Healthcare Solutions, Inc. Jan 10, 2025 | Consulting Fee EYLEA HD · OPHTHALMOLOGY | $3,315 |
| Regeneron Healthcare Solutions, Inc. Jan 10, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to AUSTIN, TX · in-kind | $168 |
| Regeneron Healthcare Solutions, Inc. Jan 10, 2025 | Travel and Lodging EYLEA HD · OPHTHALMOLOGY · travel to AUSTIN, TX · in-kind | $133 |
| Genentech USA, Inc. Jan 9, 2025 | Travel and Lodging Vabysmo · Immunology and Ophthalmology · travel to New Orleans, LA | $39.00 |
| Genentech USA, Inc. Jan 9, 2025 | Travel and Lodging Vabysmo · Immunology and Ophthalmology · travel to New Orleans, LA | $28.00 |
| Genentech USA, Inc. Jan 9, 2025 | Travel and Lodging Vabysmo · Immunology and Ophthalmology · travel to New Orleans, LA | $27.47 |
| Genentech USA, Inc. Jan 9, 2025 | Travel and Lodging Vabysmo · Immunology and Ophthalmology · travel to New Orleans, LA | $8.00 |
| Ocular Therapeutix, Inc. Jan 6, 2025 | Consulting Fee | $1,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 30 industry-funded studies in 2025, from 13 companies. The companies reported $10,627,256 in research payments for these studies, mostly to the institutions running them.
- A Randomized, Participant and Investigator Masked, Placebo-controlled, Multicenter, Proof-of-concept Study to Assess the Safety and Efficacy of LNP023 (Iptacopan) in Patients With Early and Intermediate Age-related Ma…
Novartis Pharmaceuticals Corporation - Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (axitinib Implant) in Subjects with Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. - A phase 2, multicenter, randomized, double-masked, parallel-group study to assess the efficacy and safety of KHK4951, a vascular endothelial growth factor receptor inhibitor, in patients with diabetic macular edema
Kyowa Kirin, Inc. - MAD to assess the safety tolerability and PK PD in nAMD patients
Genentech, Inc. - A phase 2, multicenter, randomized, double-masked, parallel group study to assess the efficacy and safety of KHK4951, a vascular endothelial growth factor receptor inhibitor, in patients with neovascular age-related m…
Kyowa Kirin, Inc. - A Phase 2/3, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy …
Janssen Research & Development, LLC - CT-388-104 OW/OB with T2D
Genentech, Inc. - Study of the port delivery system with ranibizumab in patients with diabetic macular edema
Genentech, Inc. - A Phase 2, Double Masked, Placebo Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients with Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)
Alexion Pharmaceuticals, Inc. - Port Delivery System of Ranibizumab Extension Study
Genentech, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.